Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 316-332

  Ota, Tsuguhito ^a   Gayet, Constance ^a   Ginsberg, Henry N ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b PH 10 305 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; GLUCOSE REGULATED PROTEIN 78; INITIATION FACTOR 2ALPHA; INTRALIPID; MESSENGER RNA; OLEIC ACID; TRIACYLGLYCEROL; TUNICAMYCIN; VERY LOW DENSITY LIPOPROTEIN; X BOX BINDING PROTEIN 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; CELL STRESS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; IN VITRO STUDY; LIVER CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RNA SPLICING; RODENT;

ANIMALS; APOLIPOPROTEIN B-100; CELL LINE; ENDOPLASMIC RETICULUM; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; LIVER; MICE; OLEIC ACID; PROTEASOME ENDOPEPTIDASE COMPLEX; STRESS; TIME FACTORS; TRIGLYCERIDES;

EID: 38149136598     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32752     Document Type: Article

References (75)

1. Harding, H.P., Calfon, M., Urano, F., Novoa, I., and Ron, D. 2002. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell. Dev. Biol. 18:575-599.
2. Kaufman, R.J., et al. 2002. The unfolded protein response in nutrient sensing and differentiation. Nat. Rev. Mol. Cell Biol. 3:411-421.
3. Mori, K. 2000. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell. 101:451-454.
4. Harding, H.P., Zhang, Y., and Ron, D. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 397:271-274.
5. Harding, H., et al. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell. 6:1099-1108.
6. Marciniak, S.J., and Ron, D. 2006. Endoplasmic reticulum stress signaling in disease. Physiol. Rev. 86:1133-1149.
7. Neuschwander-Tetri, B.A. 2007. Fatty liver and the metabolic syndrome. Curr. Opin. Gastroenterol. 23:193-198.
8. Marceau, P., et al. 1999. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab. 84:1513-1517.
9. Pagano, G., et al. 2002. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 35:367-372.
10. Utzschneider, K.M., and Kahn, S.E. 2006. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91:4753-4761.
11. Ford, E.S., Giles, W.H., and Mokdad, A.H. 2004. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 27:2444-2449.
12. Browning, J.D., et al. 2004. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40:1387-1395.
13. Ozcan, U., et al. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306:457-461.
14. Nakatani, Y., et al. 2005. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280:847-851.
15. Wellen, K.E., and Hotamisligil, G.S. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119.
16. Nakatani, Y., et al. 2004. Modulation of the JNK pathway in liver affects insulin resistance status. J. Biol. Chem. 279:45803-45809.
17. Malhi, H., Bronk, S.F., Werneburg, N.W., and Gores, G.J. 2006. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281:12093-12101.
18. Fisher, E.A., and Ginsberg, H.N. 2002. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277:17377-17380.
19. Shelness, G.S., Ingram, M.F., Huang, X.F., and DeLozier, J.A. 1999. Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly. J. Nutr. 129:456S- 462S.
20. Yao, Z., Tran, K., and McLeod, R.S. 1997. Intracellular degradation of newly synthesized apolipoprotein B. J. Lipid Res. 38:1937-1953.
21. Gaull, G., Sturman, J.A., and Schaffner, F. 1974. Homocystinuria due to cystathionine synthase deficiency: enzymatic and ultrastructural studies. J. Pediatr. 84:381-390.
22. Gulsen, M., et al. 2005. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 20:1448-1455.
23. Werstuck, G.H., et al. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107:1263-1273.
24. Macri, J., and Adeli, K. 1997. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of apoB-containing lipoprotein particles in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 17:2982-2994.
25. Ingram, M.F., and Shelness, G.S. 1996. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane. J. Lipid Res. 37:2202-2214.
26. Qiu, W., et al. 2005. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation. Arterioscler. Thromb. Vasc. Biol. 25:571-577.
27. Morris, J.A., Dorner, A.J., Edwards, C.A., Hendershot, L.M., and Kaufman, R.J. 1997. Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J. Biol. Chem. 272:4327-4334.
28. Calfon, M., et al. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415:92-96.
29. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 107:881-891.
30. Fisher, E.A., et al. 1997. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272:20427-20434.
31. Fisher, E.A., et al. 2001. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276:27855-27863.
32. Pan, M., et al. 2004. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113:1277-1287.
33. Vilatoba, M., et al. 2005. Sodium 4-phenylbutyrate protects against ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery. 138:342-351.
34. Ozcan, U., et al. 2006. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313:1137-1140.
35. Zhang, Y.-L., et al. 2004. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids 1: differential effects of delivering fatty acids via albumin or remnant-like emulsion particles. J. Biol. Chem. 279:19362-19374.
36. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
37. Avramoglu, R.K., Qiu, W., and Adeli, K. 2003. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front. Biosci. 8:d464-d476.
38. Ginsberg, H.N., Zhang, Y.L., and Hernandez-Ono, A. 2005. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 36:232-240.
39. Lewis, G.F. 1999. Fatty acid regulation of very low density lipoprotein (VLDL) production. Curr. Opin. Lipidol. 10:475-477.
40. Ozawa, K., et al. 2005. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes. 54:657-663.
41. Lee, J.N., Song, B., DeBose-Boyd, R.A., and Ye, J. 2006. Sterol-regulated degradation of insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281:39308-39315.
42. Sparks, J.D., and Sparks, C.E. 1994. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta. 1215:9-32.
43. Lewis, G.F., Uffelman, K.D., Szeto, L.W., and Steiner, G. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42:833-842.
44. Malmstrom, R., et al. 1997. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17:1454-1464.
45. Bourgeois, C.S., Wiggins, D., Hems, R., and Gibbons, G.F. 1995. VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am. J. Physiol. 269:E208-E215.
46. Taghibiglou, C., et al. 2000. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem. 275:8416-8425.
47. Malmstrom, R., et al. 1997. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 40:454-462.
48. Karaskov, E., et al. 2006. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1pancreatic β-Cell Apoptosis. Endocrinology. 147:3398-3407.
49. Cnop, M., et al. 2007. Selective inhibition of EIF2α dephosphorylation potentiates fatty acid-induced ER stress and causes pancreatic β-cell dysfunction and apoptosis. J. Biol. Chem. 282:3989-3997.
50. Wang, H., Kouri, G., and Wollheim, C.B. 2005. ER stress and SREBP-1 activation are implicated in {beta}-cell glucolipotoxicity. J. Cell Sci. 118:3905-3915.
51. Borradaile, N.M., et al. 2006. A critical role for eukaryotic elongation faction 1A-1 in lipotoxic cell death. Mol. Biol. Cell. 17:770-778.
52. Wei, Y., Wang, D., Topczewski, F., and Pagliassotti, M.J. 2006. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291:E275-E281.
53. Wang, D., Wei, Y., and Pagliassotti, M.J. 2006. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology. 147:943-951.
54. Liao, W., Hui, T.Y., Young, S.G., and Davis, R.A. 2003. Blocking microsomal triglyceride protein interferes with apoB secretion without causing retention or stress in the ER. J. Lipid Res. 44:978-985.
55. Dixon, J.L., Furukawa, S., and Ginsberg, H.N. 1991. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266:5080-5086.
56. Sakata, N., Wu, X., Dixon, J.L., and Ginsberg, H.N. 1993. Proteolysis and lipid facilitated translocation are distinct but competitive processes which regulate secretion of apolipoprotein B in HepG2 cells. J. Biol. Chem. 268:22967-22970.
57. Olofsson, S.-O., Stillemark-Billton, P., and Asp, L. 2000. Intracellular assembly of VLDL. Two major steps in separate cell compartments. Trends Cardiovasc. Med. 10:338-345.
58. Liang, J.-S., and Ginsberg, H.N. 2001. Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apoB lipoproteins from liver cells. J. Biol. Chem. 276:28606-28612.
59. Sparks, J.D., et al. 1997. Effects of fatty acids on apolipoprotein B secretion by McArdle PH-7777 rat hepatoma cells. Biochim. Biophys. Acta. 1347:51-61.
60. Zhou, M., Fisher, E.A., and Ginsberg, H.N. 1998. Regulated co-translational ubiquitination of apoliprotein B100. A new paradigm for proteasomal degradation of a secretory protein. J. Biol. Chem. 273:24649-24653.
61. Pan, M., Liang, J.S., Fisher, E.A., and Ginsberg, H.N. 2000. Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B. J. Biol. Chem. 275:27399-27405.
62. Qiu, W., Avramoglu, R.K., Rutledge, A.C., Tsai, J., and Adeli, K. 2006. Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins. J. Lipid Res. 47:1749-1761.
63. Oyadomari, S., et al. 2006. Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell. 126:727-739.
64. Shenkman, M., Tolchinsky, S., Kondratyev, M., and Lederkremer, G.Z. 2007. Transient arrest in proteasomal degradation during inhibition of translation in the unfolded protein response. Biochem. J. 404:509-516.
65. Cohen, F.E., and Kelly, J.W. 2003. Therapeutic approaches to protein-misfolding diseases. Nature. 426:905-909.
66. Rubenstein, R.C., Egan, M.E., and Zeitlin, P.L. 1997. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100:2457-2465.
67. Burrows, J.A., Willis, L.K., and Perlmutter, D.H. 2000. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc. Natl. Acad. Sci. U. S. A. 97:1796-1801.
68. McGuinness, M.C., Zhang, H.P., and Smith, K.D. 2001. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol. Genet. Metab. 74:256-263.
69. Adiels, M., et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 49:755-765.
70. Smith, S.G., and Davis, W.M. 1974. A method for chronic intravenous drug administration in the rat. In Methods in narcotics research. S. Ehrenpreis and A. Neidle, editors. Marcel Dekker. New York, New York, USA. 3-32.
71. Barr, J.E., Holmes, D.B., Ryan, L.J., and Sharpless, S.K. 1979. Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol. Biochem. Behav. 11:115-118.
72. Siri, P., et al. 2001. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B-lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity and insulin resistance. J. Biol. Chem. 276:46064-46072.
73. Scanu, A.M. 1965. Factors affecting lipoprotein metabolism. Adv. Lipid Res. 3:63-138.
74. Otway, S. 1967. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J. Physiol. 190:321-332.
75. Folch, J., and Lees, M. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 224:497-509.